Meitav Investment House’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-470
Closed -$41.9K 384
2023
Q2
$41.9K Sell
470
-72,997
-99% -$6.14M ﹤0.01% 457
2023
Q1
$6.29M Sell
73,467
-9,000
-11% -$787K 0.11% 130
2022
Q4
$7.97M Sell
82,467
-9,100
-10% -$818K 0.14% 123
2022
Q3
$6.79M Buy
91,567
+17,000
+23% +$1.41M 0.12% 128
2022
Q2
$5.88M Sell
74,567
-9,229
-11% -$814K 0.1% 132
2022
Q1
$8.15M Buy
83,796
+6,640
+9% +$629K 0.12% 128
2021
Q4
$7.17M Buy
77,156
+9,509
+14% +$895K 0.12% 139
2021
Q3
$6.37M Hold
67,647
0.1% 145
2021
Q2
$6.51M Sell
67,647
-20,782
-24% -$1.95M 0.17% 111
2021
Q1
$7.98K Buy
88,429
+20,175
+30% +$1.74M 0.22% 94
2020
Q4
$5.49M Buy
68,254
+27,948
+69% +$2.08M 0.21% 89
2020
Q3
$2.64M Buy
+40,306
New +$2.65M 0.13% 96
2019
Q3
Sell
-5,739
Closed -$379K 455
2019
Q2
$379K Buy
+5,739
New +$384K 0.03% 280
2018
Q4
Sell
-8,295
Closed -$635K 373
2018
Q3
$635K Sell
8,295
-3,012
-27% -$222K 0.03% 263
2018
Q2
$782K Sell
11,307
-2,242
-17% -$158K 0.03% 268
2018
Q1
$925K Buy
+13,549
New +$965K 0.05% 175

Other funds holding EMR

Meitav Investment House's EMR Position: Q3 2023 in Review

Meitav Investment House sold out of Emerson Electric (EMR) in Q3 2023, closing a stake of 470 shares — an estimated $41.9K sold.

Meitav Investment House first reported a position in EMR in Q1 2018 and held it in 16 quarters. The position peaked at $8.15M in Q1 2022. 1,798 funds tracked by Wall St. Rank hold EMR as of Q3 2023.

  • Meitav Investment House reported no remaining Emerson Electric position as of Q3 2023 after selling out during the quarter.
  • Meitav Investment House sold 470 Emerson Electric shares in Q3 2023, an estimated $41.9K.
  • Meitav Investment House first reported a position in Emerson Electric in Q1 2018 and held it in 16 quarters.
  • Meitav Investment House's Emerson Electric position peaked at $8.15M in Q1 2022.
  • 1,798 funds tracked by Wall St. Rank held Emerson Electric as of Q3 2023.

Based on Meitav Investment House's 13F filing for Q3 2023, filed 30 Oct 2023.